Zoll Expands Manufacturing Business in Silicon Valley by Purchasing New Building in San Jose
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that as a result of its continued growth it purchased a 124,500-square-foot building in San Jose, California, an area ranked as the country’s busiest advanced manufacturing corridor1.
ZOLL will transition from Sunnyvale, California, to its new facility on Ringwood Avenue following a renovation, which gets underway in January 2014.
“We are thrilled by the demand for ZOLL’s temperature management business, which has grown at a consistent rate since it began in 2009,” said James Palazzolo, President of ZOLL. “We currently employ 225 highly skilled professionals, and the move to San Jose will allow us to continue our growth by giving us the space we need to add jobs and support new products, acquire new businesses, and insource key operations in our supply chain.”
“I’m pleased to welcome ZOLL to San Jose,” Mayor Chuck Reed said. “As the Capital of Silicon Valley, there is no better place in the world for advanced manufacturing companies to start and grow their business. I thank ZOLL for investing in San Jose and for their commitment to creating more jobs in Silicon Valley.”
ZOLL’s California operation is responsible for the development and manufacture of the company’s intravascular temperature management system (IVTM™) and the AutoPulse® Non-invasive Cardiac Support Pump. ZOLL IVTM offers health care providers the power and control they need to rapidly, safely, and effectively manage the core body temperature of critically ill or surgical patients. The revolutionary AutoPulse is an automated, portable chest compression device. It is the only mechanical CPR system to have shown improved survival in comparative clinical trials2.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 25,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
2Wik L, et al. The impact of CPR duration on survival to discharge between integrated AutoPulse-CPR and manual–CPR during out-of-hospital cardiac arrest of presumed cardiac origin. Resuscitation. 2012;83:e17